THC Percentages: How to Read Cannabis Lab Numbers

THC percentage — short for tetrahydrocannabinol percentage — is a measurement of how much of a specific cannabinoid is present in a cannabis sample relative to the sample’s total weight. It is expressed as a weight-per-weight percentage: a product labeled “22% THC” contains approximately 220 milligrams of the measured compound per gram of sample weight (1,000mg × 0.22 = 220mg/g).

The critical first complication is that raw, unheated cannabis does not primarily contain THC at all. It contains THCA (tetrahydrocannabinolic acid) — the acidic precursor to THC. THCA is non-psychoactive. Your body does not convert THCA to THC at body temperature; the conversion requires heat, specifically the process of decarboxylation, which removes the carboxylic acid group (CO2) from the THCA molecule. This happens during smoking, vaporization, and baking. Raw cannabis consumed without heat does not produce psychoactive effects from THCA.

When a dispensary menu lists “28% THC” on a flower product, what is almost always displayed is either: the THCA percentage alone (mislabeled as THC), the calculated total THC after applying the decarboxylation conversion formula, or sometimes the sum of THCA and delta-9 THC without the conversion factor. Inconsistency in what the label actually represents is a persistent problem in cannabis retail, and understanding the difference requires reading the actual COA rather than relying on the menu display number.

THCA vs. Delta-9 THC vs. Total THC: The Three Numbers

On a properly formatted Certificate of Analysis cannabinoid panel, you will see at minimum three cannabis-related numbers: THCA%, delta-9 THC%, and typically “Total THC%” (the calculated value). Here is what each means:

• THCA%: The concentration of tetrahydrocannabinolic acid in the raw sample. This is the dominant cannabinoid in most commercial flower — typically 15–30% by weight in dispensary-quality products. THCA is non-psychoactive until decarboxylated.
• Delta-9 THC%: The concentration of active, decarboxylated THC already present in the sample before heating. In properly cured flower, this is usually 0.1–2% — a small fraction of total cannabinoids. Cannabis that has been poorly cured, stored too warm, or exposed to prolonged light may show higher delta-9 as degradation has partially decarboxylated the THCA.
• Total THC%: The calculated maximum psychoactive THC available if the entire THCA content were perfectly decarboxylated. Formula: (THCA × 0.877) + delta-9 THC. This is the most useful single potency number for consumers, representing what is theoretically achievable with efficient combustion or vaporization.

Note that “total THC” is a theoretical maximum — no consumer achieves 100% decarboxylation efficiency in practice. Inefficient inhalation technique, combustion temperatures that are too high or too low, and incomplete vaporization all reduce actual delivered THC below the calculated total. The practical delivered THC through smoking is typically 20–37% of the labeled total THC, varying substantially with technique and device.

The 0.877 conversion factor is derived from the molecular weights of THCA and THC. THCA has a molecular weight of 358.47 g/mol; THC has a molecular weight of 314.46 g/mol. The ratio is 314.46 ÷ 358.47 = 0.8773 — meaning that when 1 gram of THCA decarboxylates, the CO2 loss produces 0.877 grams of THC.

Practical worked examples:

Notice that the “28% THC” product on a dispensary menu showing raw THCA may have a true total THC of only 24.8% — nearly 3.5 percentage points lower than the headline number. This gap is most significant at higher THCA concentrations and is one of the most consistent sources of confusion for cannabis consumers.

Even in a world of perfectly honest labs, cannabis THC testing has inherent analytical variance. This variance has multiple sources: the heterogeneity of the cannabis flower sample itself (different parts of the bud have different cannabinoid concentrations), instrument calibration differences between labs, sample preparation methodology (solvent choice, extraction technique), and the specific analytical method used (HPLC vs. GC).

Industry-accepted analytical variance for cannabis potency testing is approximately ±3% in absolute terms at typical potency levels. This means a product that “truly” contains 22% total THC could be reported as anywhere from 19% to 25% by different ISO 17025-accredited laboratories using correct procedures. This is not fraud — it is the unavoidable consequence of measuring a complex biological matrix with inherent heterogeneity.

The Lab Shopping Problem and Systematic Overstatement

Beyond natural analytical variance, a 2021 study published in Cannabis and Cannabinoid Research documented systematic and substantial upward bias in commercially reported cannabis THC percentages. Researchers obtained cannabis products from licensed Colorado dispensaries and tested them at a reference laboratory using validated reference methods. The commercial labs’ reported values exceeded the reference laboratory’s results by an average of 23.1%.

The cause is structural: cannabis producers competing for shelf space in a market where consumers disproportionately select high-THC products have financial incentives to submit samples to multiple labs and report only the highest result. Labs that report lower, more accurate values lose business to competitors willing to report higher numbers. Absent regulatory intervention requiring blind proficiency testing and inter-lab comparison programs, the commercial incentive for upward bias is self-reinforcing.

The practical consumer implication: a flower product labeled 28% THC at a licensed Colorado dispensary likely contains closer to 22–23% actual THC by reference standards. This does not mean the product is unsafe or mislabeled in a fraudulent sense — it is a systemic accuracy problem affecting the entire industry, not individual fraud. But it does mean that the labeled number should be treated as a rough directional reference, not a precise measurement, and that comparing THC percentages across different brands should account for the reality that different producers’ labs may be measuring differently.

State Regulatory Responses to Potency Inflation

Several state cannabis regulatory bodies have begun addressing potency inflation through inter-laboratory proficiency programs. Oregon requires licensed labs to participate in blind proficiency testing managed by OLCC. Colorado has implemented accreditation requirements and standardized testing methodologies for licensed labs. California’s Bureau of Cannabis Control has issued guidance on sampling and testing consistency. Massachusetts requires labs to perform precision and accuracy testing against reference standards. These programs are improving accuracy over time, but the 2021 study’s findings suggest the gap between commercial reporting and reference laboratory values remains substantial in most markets.

The research on whether THC percentage actually predicts experience quality is now substantial and consistently points in the same direction: it does not, with meaningful reliability.

The University of Colorado study is particularly important because it used real consumers in naturalistic settings — not controlled laboratory exposure — and measured both blood THC levels and subjective intoxication. The finding that there was no significant association between the THC% of the product consumed and the magnitude of the experience directly contradicts the dominant consumer belief that higher THC% = stronger high. Individual variation, tolerance, and the product’s full chemical profile account for far more variance than the headline number.

The same percentage label means very different things across different product categories because the total cannabinoid dose delivered per use varies enormously. Here is how to translate percentage into actual delivered dose across formats:

The edible comparison is particularly important: edibles are not labeled in percentage but in milligrams per serving. When cannabis is ingested, hepatic first-pass metabolism converts delta-9 THC into 11-hydroxy-THC, a more potent metabolite with enhanced blood-brain barrier penetration. This is why edibles feel “different” than inhaled cannabis at equivalent doses — they are chemically different compounds affecting the brain in different ways, not simply the same compound at the same concentration.

Given everything above, here is a practical decision framework for using THC% as one input — not the only input — in a cannabis purchase decision:

A full-panel COA or detailed menu listing shows more than just THC. Understanding the minor cannabinoids gives a more complete picture of what a product will deliver:

CBD (cannabidiol): Modulates THC’s psychoactive and anxiogenic effects by competing at CB1 receptors and through allosteric modification. Even small amounts of CBD (4–8mg) can meaningfully reduce THC-induced anxiety in susceptible individuals. Products with even a modest CBD-to-THC ratio of 1:4 will feel different from a THC-only product of the same total potency.

CBG (cannabigerol): Often called the “mother cannabinoid” as it is the biosynthetic precursor to most other cannabinoids. Non-psychoactive. Some research suggests anti-inflammatory and neuroprotective properties. “CBG-dominant” strains have emerged as a consumer category.

CBN (cannabinol): A degradation product of THC formed over time with heat and light exposure. Mildly psychoactive. Often marketed in sleep products for its reported sedative properties, though the clinical evidence base is limited. Products with detectable CBN percentages may be from older harvests or include CBN as an intentional additive.

THCV (tetrahydrocannabivarin): A homolog of THC with distinct pharmacology. At low doses, THCV may act as a CB1 antagonist (opposing some THC effects). At higher doses, partial agonism. Often described as producing a clear-headed, energetic effect. Found in significant concentrations in some African sativa cultivars (Durban Poison, Doug’s Varin).

Understanding these minor cannabinoids provides a richer picture of what a product will deliver than THC% alone. Dispensary menus that provide full cannabinoid panels are giving consumers genuinely useful purchasing data — not just marketing numbers. See our COA reading guide for a complete panel interpretation guide and our terpene library for terpene-specific information.